Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100366568> ?p ?o ?g. }
- W3100366568 endingPage "22312" @default.
- W3100366568 startingPage "22291" @default.
- W3100366568 abstract "Background Numerous studies proved that long non-coding RNA (lncRNA) is involved in the progression of multifarious diseases, especially in some carcinomas. As a potential tumor biomarker, plasmacytoma variant translocation 1 gene (PVT1) is involved in the development and progression of multifarious cancers. Nevertheless, the intrinsic and concrete molecular mechanism of PVT1 in bladder cancer still remained unclear, which is also the dilemma faced in many non-coding RNA studies. Results Our research revealed that PVT1 was significantly higher expression in bladder carcinoma specimens and cell lines. Further experiments indicated that knockdown or overexpression of PVT1 restrained or promoted the malignant phenotype and WNT/β-catenin signaling in bladder cancer cells. Meanwhile miR-194-5p was in contrast and miR-194-5p could partially reverse the function of PVT1 in malignant bladder tumor cells. As a microRNA sponge, PVT1 actively promotes the expression of b-cells lymphoma-2-associated transcription factor 1 (BCLAF1) to sponge miR-194-5p and subsequently increases malignant phenotypes of bladder cancer cells. Therefore, it performs a carcinogenic effect and miR-194-5p as the opposite function, and serves as an antioncogene in the bladder carcinomas pathogenesis. Conclusion PVT1-miR-194-5p-BCLAF1 axis is involved in the malignant progression and development of bladder carcinomas. Experiments revealed that PVT1 has a significant regulatory effect on bladder cancer (BC) and can be used as a clinical diagnostic marker and a therapeutic molecular marker for patients suffering from BC. Methods In urothelial bladder carcinoma specimens and cell lines, the relative expression levels of PVT1 and miR-194-5p were detected by quantitative reverse transcription PCR (RT-qPCR). Through experiments such as loss-function and over-expression, the biological effects of PVT1 and miR-194-5p on the proliferation, migration, apoptosis and tumorigenicity were explored in bladder cancer cells. Co-immunoprecipitation, proteomics experiments, dual luciferase reporter gene analysis, western blot and other methods were adopted to investigate the PVT1 potential mechanism in bladder carcinomas." @default.
- W3100366568 created "2020-11-23" @default.
- W3100366568 creator A5026221574 @default.
- W3100366568 creator A5055054623 @default.
- W3100366568 creator A5055817822 @default.
- W3100366568 creator A5059690167 @default.
- W3100366568 creator A5061707266 @default.
- W3100366568 creator A5065949033 @default.
- W3100366568 creator A5069483614 @default.
- W3100366568 creator A5070346853 @default.
- W3100366568 creator A5075639297 @default.
- W3100366568 creator A5085008850 @default.
- W3100366568 date "2020-11-16" @default.
- W3100366568 modified "2023-10-17" @default.
- W3100366568 title "LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA" @default.
- W3100366568 cites W1938121151 @default.
- W3100366568 cites W2081410358 @default.
- W3100366568 cites W2310344966 @default.
- W3100366568 cites W2407160791 @default.
- W3100366568 cites W2460573931 @default.
- W3100366568 cites W2585735115 @default.
- W3100366568 cites W2591100606 @default.
- W3100366568 cites W2765829825 @default.
- W3100366568 cites W2795679584 @default.
- W3100366568 cites W2895999225 @default.
- W3100366568 cites W2896934872 @default.
- W3100366568 cites W2911427769 @default.
- W3100366568 cites W2911881797 @default.
- W3100366568 cites W2930633744 @default.
- W3100366568 cites W2934209063 @default.
- W3100366568 cites W2938221680 @default.
- W3100366568 cites W2947532125 @default.
- W3100366568 cites W2947925676 @default.
- W3100366568 cites W2948917973 @default.
- W3100366568 cites W2956861681 @default.
- W3100366568 cites W2959018175 @default.
- W3100366568 cites W2960292936 @default.
- W3100366568 cites W2967723576 @default.
- W3100366568 cites W2969309057 @default.
- W3100366568 cites W2973529099 @default.
- W3100366568 cites W2979515407 @default.
- W3100366568 cites W2980984315 @default.
- W3100366568 cites W2981268273 @default.
- W3100366568 cites W2984443131 @default.
- W3100366568 cites W2984884798 @default.
- W3100366568 cites W2986360195 @default.
- W3100366568 cites W2991719227 @default.
- W3100366568 cites W2994854660 @default.
- W3100366568 cites W2994919812 @default.
- W3100366568 cites W2994940554 @default.
- W3100366568 cites W2995091413 @default.
- W3100366568 cites W2995337481 @default.
- W3100366568 cites W2996094921 @default.
- W3100366568 cites W2996111032 @default.
- W3100366568 cites W2997100294 @default.
- W3100366568 cites W2997827226 @default.
- W3100366568 cites W2998254891 @default.
- W3100366568 cites W2999843446 @default.
- W3100366568 cites W3002794853 @default.
- W3100366568 cites W3004619357 @default.
- W3100366568 cites W3005742316 @default.
- W3100366568 cites W3006202812 @default.
- W3100366568 cites W3014453357 @default.
- W3100366568 cites W3016459825 @default.
- W3100366568 cites W3016485866 @default.
- W3100366568 cites W3016997517 @default.
- W3100366568 cites W3031138550 @default.
- W3100366568 cites W3032918836 @default.
- W3100366568 cites W3034136283 @default.
- W3100366568 cites W3034722890 @default.
- W3100366568 cites W3037036500 @default.
- W3100366568 cites W3037989169 @default.
- W3100366568 cites W3040802444 @default.
- W3100366568 cites W3046970060 @default.
- W3100366568 cites W3084231133 @default.
- W3100366568 cites W3087195486 @default.
- W3100366568 doi "https://doi.org/10.18632/aging.202203" @default.
- W3100366568 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7695393" @default.
- W3100366568 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33188158" @default.
- W3100366568 hasPublicationYear "2020" @default.
- W3100366568 type Work @default.
- W3100366568 sameAs 3100366568 @default.
- W3100366568 citedByCount "29" @default.
- W3100366568 countsByYear W31003665682021 @default.
- W3100366568 countsByYear W31003665682022 @default.
- W3100366568 countsByYear W31003665682023 @default.
- W3100366568 crossrefType "journal-article" @default.
- W3100366568 hasAuthorship W3100366568A5026221574 @default.
- W3100366568 hasAuthorship W3100366568A5055054623 @default.
- W3100366568 hasAuthorship W3100366568A5055817822 @default.
- W3100366568 hasAuthorship W3100366568A5059690167 @default.
- W3100366568 hasAuthorship W3100366568A5061707266 @default.
- W3100366568 hasAuthorship W3100366568A5065949033 @default.
- W3100366568 hasAuthorship W3100366568A5069483614 @default.
- W3100366568 hasAuthorship W3100366568A5070346853 @default.
- W3100366568 hasAuthorship W3100366568A5075639297 @default.
- W3100366568 hasAuthorship W3100366568A5085008850 @default.
- W3100366568 hasBestOaLocation W31003665681 @default.